Biogen Revenue 2006-2019 | BIIB

Biogen annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Biogen revenue for the quarter ending June 30, 2019 was $3.617B, a 7.75% increase year-over-year.
  • Biogen revenue for the twelve months ending June 30, 2019 was $14.072B, a 9.32% increase year-over-year.
  • Biogen annual revenue for 2018 was $13.453B, a 9.61% increase from 2017.
  • Biogen annual revenue for 2017 was $12.274B, a 7.21% increase from 2016.
  • Biogen annual revenue for 2016 was $11.449B, a 6.36% increase from 2015.
Biogen Annual Revenue
(Millions of US $)
2018 $13,453
2017 $12,274
2016 $11,449
2015 $10,764
2014 $9,703
2013 $6,932
2012 $5,516
2011 $5,049
2010 $4,716
2009 $4,377
2008 $4,098
2007 $3,172
2006 $2,683
2005 $2,423
Biogen Quarterly Revenue
(Millions of US $)
Q2 2019 $3,617
Q1 2019 $3,490
Q4 2018 $3,526
Q3 2018 $3,439
Q2 2018 $3,357
Q1 2018 $3,131
Q4 2017 $3,307
Q3 2017 $3,078
Q2 2017 $3,078
Q1 2017 $2,811
Q4 2016 $2,872
Q3 2016 $2,956
Q2 2016 $2,894
Q1 2016 $2,727
Q4 2015 $2,839
Q3 2015 $2,778
Q2 2015 $2,592
Q1 2015 $2,555
Q4 2014 $2,641
Q3 2014 $2,511
Q2 2014 $2,421
Q1 2014 $2,130
Q4 2013 $1,966
Q3 2013 $1,828
Q2 2013 $1,723
Q1 2013 $1,415
Q4 2012 $1,418
Q3 2012 $1,386
Q2 2012 $1,421
Q1 2012 $1,292
Q4 2011 $1,327
Q3 2011 $1,310
Q2 2011 $1,209
Q1 2011 $1,203
Q4 2010 $1,219
Q3 2010 $1,176
Q2 2010 $1,213
Q1 2010 $1,109
Q4 2009 $1,127
Q3 2009 $1,121
Q2 2009 $1,093
Q1 2009 $1,036
Q4 2008 $1,069
Q3 2008 $1,093
Q2 2008 $993
Q1 2008 $942
Q4 2007 $893
Q3 2007 $789
Q2 2007 $773
Q1 2007 $716
Q4 2006 $708
Q3 2006 $703
Q2 2006 $660
Q1 2006 $611
Q4 2005 $633
Q3 2005 $596
Q2 2005 $606
Q1 2005 $588
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $41.986B $13.453B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $119.526B 13.61
Gilead Sciences (GILD) United States $79.622B 9.78
Celgene (CELG) United States $66.133B 10.23
Vertex Pharmaceuticals (VRTX) United States $46.554B 50.31
Illumina (ILMN) United States $41.861B 49.18
CSL (CSLLY) Australia $34.685B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.193B 14.61
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.450B 12.89
Incyte (INCY) United States $17.337B 51.02
Exact Sciences (EXAS) United States $15.308B 0.00
SINO PHARMACEUT (SBMFF) China $15.039B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.873B 0.00
Genmab (GNMSF) Denmark $12.608B 64.09
Seattle Genetics (SGEN) United States $12.406B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.477B 50.81
Guardant Health (GH) United States $9.197B 0.00
Sarepta Therapeutics (SRPT) United States $9.067B 0.00
Alnylam Pharmaceuticals (ALNY) United States $8.715B 0.00
Galapagos (GLPG) Belgium $8.688B 0.00
QIAGEN (QGEN) Netherlands $7.764B 25.50
Bio-Techne Corp (TECH) United States $7.304B 50.48
BeiGene (BGNE) Cayman Islands $6.704B 0.00
Bluebird Bio (BLUE) United States $6.466B 0.00
Exelixis (EXEL) United States $6.040B 15.70
Amarin (AMRN) Ireland $5.158B 0.00
Horizon Pharma Public (HZNP) Ireland $5.004B 12.72
Ascendis Pharma (ASND) Denmark $4.838B 0.00
Repligen (RGEN) United States $4.555B 88.40
ARGENX SE-ADR (ARGX) Netherlands $4.335B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.193B 0.00
Moderna (MRNA) United States $4.183B 0.00
Blueprint Medicines (BPMC) United States $4.014B 0.00
Spark Therapeutics (ONCE) United States $3.853B 0.00
China Biologic Products (CBPO) China $3.821B 23.85
MorphoSys AG (MOR) Germany $3.777B 0.00
Mirati Therapeutics (MRTX) United States $3.541B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.281B 0.00
Alkermes (ALKS) Ireland $3.276B 0.00
Immunomedics (IMMU) United States $2.759B 0.00
Genomic Health (GHDX) United States $2.752B 51.61
Arena Pharmaceuticals (ARNA) United States $2.635B 5.66
NeoGenomics (NEO) United States $2.549B 136.33
Amicus Therapeutics (FOLD) United States $2.544B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.520B 0.00
Medicines (MDCO) United States $2.501B 0.00
MyoKardia (MYOK) United States $2.460B 0.00
Acceleron Pharma (XLRN) United States $2.372B 0.00
Halozyme Therapeutics (HALO) United States $2.319B 0.00
Emergent Biosolutions (EBS) United States $2.223B 33.40
Reata Pharmaceuticals (RETA) United States $2.197B 0.00
UniQure (QURE) Netherlands $2.120B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.113B 0.00
Cambrex (CBM) United States $2.012B 25.43
Zai Lab (ZLAB) China $1.944B 0.00
Akcea Therapeutics (AKCA) United States $1.914B 0.00
Ligand Pharmaceuticals (LGND) United States $1.745B 22.06
Myriad Genetics (MYGN) United States $1.714B 17.98
Denali Therapeutics (DNLI) United States $1.689B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.585B 0.00
Insmed (INSM) United States $1.382B 0.00
AnaptysBio (ANAB) United States $1.352B 0.00
RA PHARMCTL INC (RARX) United States $1.350B 0.00
REGENXBIO (RGNX) United States $1.308B 0.00
Coherus BioSciences (CHRS) United States $1.291B 0.00
Sangamo Therapeutics (SGMO) United States $1.278B 0.00
Editas Medicine (EDIT) United States $1.256B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.212B 0.00
Epizyme (EPZM) United States $1.168B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.165B 0.00
Fate Therapeutics (FATE) United States $1.150B 0.00
Athenex (ATNX) United States $1.145B 0.00
Innoviva (INVA) United States $1.136B 3.28
Alector (ALEC) United States $1.023B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.997B 0.00
Zymeworks (ZYME) Canada $0.979B 0.00
Twist Bioscience (TWST) United States $0.938B 0.00
Cara Therapeutics (CARA) United States $0.900B 0.00
Principia Biopharma (PRNB) United States $0.868B 452.88
BAVARIAN NORDIC (BVNRY) Denmark $0.853B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.821B 0.00
Intellia Therapeutics (NTLA) United States $0.820B 0.00
ANI Pharmaceuticals (ANIP) United States $0.812B 13.55
Adverum Biotechnologies (ADVM) United States $0.804B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.794B 28.67
Arvinas (ARVN) United States $0.783B 0.00
Codexis (CDXS) United States $0.777B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.774B 0.00
Anika Therapeutics (ANIK) United States $0.760B 26.90
Cytokineticsorporated (CYTK) United States $0.733B 0.00
Retrophin (RTRX) United States $0.730B 0.00
Pharming Group (PHGUF) Netherlands $0.730B 0.00
WAVE Life Sciences (WVE) Singapore $0.697B 0.00
Vericel (VCEL) United States $0.688B 0.00
Zealand Pharma (ZLDPF) Denmark $0.672B 0.00
Zealand Pharma (ZEAL) Denmark $0.670B 7.77
Achillion Pharmaceuticals (ACHN) United States $0.659B 0.00
Stemline Therapeutics (STML) United States $0.634B 0.00
Heska (HSKA) United States $0.561B 72.73
MiMedx (MDXG) United States $0.555B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.535B 0.00
DBV Technologies S.A (DBVT) France $0.529B 0.00
Intra-Cellular Therapies (ITCI) United States $0.498B 0.00
Cellectis S.A (CLLS) France $0.489B 0.00
Revance Therapeutics (RVNC) United States $0.481B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Mesoblast (MESO) Australia $0.452B 0.00
Precision BioSciences (DTIL) United States $0.445B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.438B 0.00
UROGEN PHARMA (URGN) United States $0.429B 0.00
Syros Pharmaceuticals (SYRS) United States $0.418B 0.00
CytomX Therapeutics (CTMX) United States $0.412B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.402B 0.00
BioDelivery Sciences (BDSI) United States $0.385B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.385B 0.00
Agenus (AGEN) United States $0.380B 0.00
PHARMA MAR SA (PHMMF) Spain $0.374B 0.00
Merus (MRUS) Netherlands $0.369B 0.00
Puma Biotechnology (PBYI) United States $0.367B 0.00
Avid Bioservices (CDMO) United States $0.360B 0.00
AC Immune SA (ACIU) Switzerland $0.347B 25.70
Arcus Biosciences (RCUS) United States $0.326B 0.00
Gritstone Oncology (GRTS) United States $0.323B 0.00
Biofrontera AG (BFRA) Germany $0.323B 0.00
Bellus Health (BLUSF) Canada $0.314B 0.00
Starpharma Holdings (SPHRY) Australia $0.310B 0.00
Kadmon Holdings (KDMN) United States $0.310B 0.00
Scholar Rock Holding (SRRK) United States $0.309B 0.00
Theratechnologies (THERF) Canada $0.308B 0.00
Prothena (PRTA) Ireland $0.303B 0.00
PDL BioPharma (PDLI) United States $0.291B 7.50
Clovis Oncology (CLVS) United States $0.284B 0.00
Albireo Pharma (ALBO) United States $0.282B 0.00
Kindred Biosciences (KIN) United States $0.272B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.271B 0.00
Sorrento Therapeutics (SRNE) United States $0.271B 0.00
Protagonist Therapeutics (PTGX) United States $0.263B 0.00
Geron (GERN) United States $0.262B 0.00
Dynavax Technologies (DVAX) United States $0.255B 0.00
Senesco Technologies (ELOX) United States $0.247B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.242B 0.00
Cellular Biomedicine (CBMG) United States $0.238B 0.00
ADMA Biologics Inc (ADMA) United States $0.231B 0.00
ChromaDex (CDXC) United States $0.231B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.225B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.225B 0.00
Inovio Pharmaceuticals (INO) United States $0.217B 0.00
Kamada (KMDA) Israel $0.212B 8.09
Five Prime Therapeutics (FPRX) United States $0.211B 0.00
PHASEBIO PHARMA (PHAS) United States $0.204B 0.00
Seres Therapeutics (MCRB) United States $0.199B 0.00
MannKind (MNKD) United States $0.197B 0.00
Sutro Biopharma (STRO) United States $0.196B 0.00
Athersys (ATHX) United States $0.188B 0.00
Compugen (CGEN) Israel $0.182B 0.00
Spero Therapeutics (SPRO) United States $0.179B 0.00
Cue Biopharma (CUE) United States $0.171B 0.00
Affimed (AFMD) Germany $0.168B 0.00
POXEL SA FRANCE (PXXLF) $0.167B 0.00
Dyadic (DYAI) United States $0.167B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Novavax (NVAX) United States $0.158B 0.00
Emmaus Life Sciences (EMMA) United States $0.157B 0.00
Cerecor (CERC) United States $0.154B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.153B 0.00
Arsanis (XFOR) United States $0.152B 0.00
Nicox SA (NICXF) France $0.150B 0.00
OSMOTICA PHARM (OSMT) United States $0.149B 0.00
Enzo Biochem (ENZ) United States $0.147B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.147B 0.00
XOMA (XOMA) United States $0.144B 0.00
Synlogic (SYBX) United States $0.143B 0.00
Strongbridge Biopharma (SBBP) United States $0.140B 5.76
Lexicon Pharmaceuticals (LXRX) United States $0.140B 0.00
Adocia (ADOCY) France $0.140B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.136B 0.00
Mersana Therapeutics (MRSN) United States $0.132B 0.00
Prometic Life Sciences (PFSCF) Canada $0.130B 0.00
Acorda Therapeutics (ACOR) United States $0.126B 0.00
Alcobra (ARCT) United States $0.126B 0.00
Windtree Therapeutics (WINT) United States $0.126B 0.00
NantKwest (NK) United States $0.122B 0.00
Northwest Biotherapeutics (NWBO) United States $0.120B 0.00
Liquidia Technologies (LQDA) United States $0.117B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.114B 0.00
Celyad SA (CYAD) Belgium $0.113B 0.00
SESEN BIO, INC (SESN) United States $0.112B 0.00
Aptinyx (APTX) United States $0.110B 0.00
Aduro Biotech (ADRO) United States $0.108B 0.00
Abeona Therapeutics (ABEO) United States $0.107B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.107B 0.00
Fortress Biotech (FBIO) United States $0.106B 0.00
TOCAGEN INC (TOCA) United States $0.104B 0.00
Checkpoint Therapeutics (CKPT) United States $0.103B 0.00
Verastem (VSTM) United States $0.096B 0.00
OvaScience (MLND) United States $0.091B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.088B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.087B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.086B 0.00
Catalyst Biosciences (CBIO) United States $0.085B 0.00
Trevena (TRVN) United States $0.083B 0.00
Arbutus Biopharma (ABUS) Canada $0.081B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.080B 0.00
Menlo Therapeutics (MNLO) United States $0.078B 0.00
Selecta Biosciences (SELB) United States $0.074B 0.00
Vaccinex (VCNX) United States $0.073B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
ARAVIVE, INC (ARAV) United States $0.069B 0.00
VTv Therapeutics (VTVT) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.067B 0.00
AquaBounty Technologies (AQB) United States $0.066B 0.00
Curis (CRIS) United States $0.065B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.064B 0.00
Antibe Therapeutics (ATBPF) Canada $0.062B 0.00
Idera Pharmaceuticals (IDRA) United States $0.061B 0.00
VBI Vaccines (VBIV) United States $0.060B 0.00
Oncobiologics (OTLK) United States $0.058B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
AIT Therapeutics (XAIR) United States $0.056B 0.00
Applied Genetic Technologies (AGTC) United States $0.055B 30.00
Prima BioMed (IMMP) Australia $0.054B 0.00
Pluristem Therapeutics (PSTI) Israel $0.054B 0.00
China Health Industries Holdings (CHHE) China $0.054B 20.47
Unum Therapeutics (UMRX) United States $0.054B 0.00
Invo BioScience (IVOB) United States $0.051B 0.00
Ophthotech (ISEE) United States $0.046B 0.00
Clearside Biomedical (CLSD) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
Evogene (EVGN) Israel $0.039B 0.00
VIVUS (VVUS) United States $0.037B 0.00
Organovo Holdings (ONVO) United States $0.036B 0.00
Celsion (CLSN) United States $0.036B 0.00
Alimera Sciences (ALIM) United States $0.036B 0.00
Apricus Biosciences (SEEL) United States $0.036B 0.00
AEterna Zentaris (AEZS) United States $0.035B 0.00
Aptevo Therapeutics (APVO) United States $0.033B 0.00
Proteostasis Therapeutics (PTI) United States $0.032B 0.00
Celldex Therapeutics (CLDX) United States $0.032B 0.00
BIOCARDIA INC (BCDA) United States $0.032B 0.00
DiaMedica Therapeutics (DMAC) United States $0.031B 0.00
Entera Bio (ENTX) Israel $0.030B 0.20
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Signal Genetics (MGEN) United States $0.026B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.025B 0.00
Aytu Bioscience (AYTU) United States $0.022B 0.00
Soligenix (SNGX) United States $0.021B 0.00
VistaGen Therapeutics (VTGN) United States $0.021B 0.00
Bionano Genomics (BNGO) United States $0.018B 0.00
Vical (VICL) United States $0.018B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 6.00
TRACON Pharmaceuticals (TCON) United States $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
CollPlant Holdings (CLGN) Israel $0.013B 0.00
Novelion Therapeutics (NVLN) Canada $0.013B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
TrovaGene (TROV) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.007B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Stellar Biotechnologies (EDSA) Canada $0.004B 0.00
Neuralstem (CUR) United States $0.002B 0.00